Skip to main content
Premium Trial:

Request an Annual Quote

Don't Mention Preprints

An open letter with more than 600 signatories is calling on the Australian Research Council to rescind a change made to a grant application rule, according to the Guardian.

It adds the ARC recently tweaked a rule so that grant applicants would no longer be able to cite preprints in their funding proposals. Previously, applicants were only barred from listing preprints in the CV section of their proposals, Times Higher Education notes. Now, according to the Australian Financial Review, any application that refers at all to a preprint is disqualified from receiving funding. This change, THE says, caught applicants for Future Fellowship and Discovery Early Career Researcher Award grants off-guard.

The Guardian reports that John Shine, the president of the Australian Academy of Science, wrote to Alan Tudge, the federal education minister, to express concerns about the rule change. "It could easily be argued that a researcher not referencing material found in preprints is not using the full range of contemporary knowledge in a discipline," Shine wrote.

Additionally, an open letter to Tudge and Sue Thomas, the chief executive of ARC, that argues that referencing preprints in funding applications is essential to be able to best weigh a proposal's novelty and value has drawn more than 600 signatures, the Guardian says.

The ARC is now looking into the rule change, it adds.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.